Memantina Teva

Memantine, the active ingredient in Memantina Teva, is a NMDA receptor antagonist presented as a tablet for oral use. It is indicated for the treatment of moderate to severe Alzheimer’s disease in adult patients. GNH USA supplies Memantina Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Memantine is an NMDA‑receptor antagonist used in the management of neurodegenerative disorders, primarily Alzheimer’s disease. - Alzheimer’s disease (moderate to severe): improves cognition, memory and daily functioning. - Alzheimer’s disease (mild to moderate) as add‑on therapy: may provide additional cognitive benefit when combined with a cholinesterase inhibitor. - Behavioral symptoms of Alzheimer’s disease: may reduce agitation and aggression associated with the condition.

Memantina Teva may cause a range of adverse reactions.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate intensity. - Constipation: reduced bowel movements. - Fatigue: feeling unusually tired. - Confusion: transient disorientation. - Nausea: mild stomach upset.

Serious or Rare Side Effects: - Seizures: rare occurrence of convulsive episodes. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Hallucinations: visual or auditory disturbances. - Mood changes: depression or suicidal thoughts. - Hyponatremia: low blood sodium levels. - Cardiac arrhythmia: irregular heart rhythm.

Before initiating therapy, consider the following safety points. - Renal impairment: dose may need adjustment in patients with reduced kidney function. - Hepatic disease: monitor liver enzymes in patients with liver dysfunction. - History of seizures: use with caution and monitor for convulsions. - Concomitant use of other NMDA antagonists: avoid additive neuro‑psychiatric effects. - Pregnancy and breastfeeding: safety not established; weigh potential benefits against risks. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Memantina Teva can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Amantadine: combined NMDA antagonism may increase neuro‑psychiatric side effects. - Ketamine: additive CNS depression and dissociative effects. - High‑dose quinidine: may raise memantine plasma concentrations.

Moderate Interactions (Monitor Closely): - Anticholinesterase inhibitors (e.g., donepezil): monitor for enhanced cognitive effects. - Diuretics (e.g., furosemide): watch for electrolyte disturbances, especially hyponatremia. - Antihypertensives: possible additive hypotensive effect.